Skip to search formSkip to main contentSkip to account menu

Anti-psoriatic Agent

Used topically or systemically, natural or synthetic Anti-psoriatic agents relieve symptoms of psoriasis by controlling rapid growth of skin cells… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Antipsoriatic potential of Annona squamosa seed oil: An in vitro and in vivo evaluation.
2018
2018
The Therapeutic Potential and Molecular Mechanism of Isoflavone Extract against Psoriasis
Psoriasis is a common inflammatory disease. It affects 1–3% of the population worldwide and is associated with increasing medical… 
2016
2016
Dimethylfumarate inhibits melanoma cell proliferation via p21 and p53 induction and bcl-2 and cyclin B1 downregulation
Recent evidence suggests that dimethylfumarate (DMF), known as a highly potent anti-psoriatic agent, might have anti-tumorigenic… 
Review
2014
Review
2014
IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease.
Highly Cited
2007
Highly Cited
2007
Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
Highly Cited
2001
Highly Cited
2001
In vitro keratinocyte antiproliferant effect of Centella asiatica extract and triterpenoid saponins.
Psoriasis is a hyperproliferative skin disorder estimated to be present in 1-3% of most populations. Conventional therapy using… 
Review
2001
Review
2001
New dermatological agents for the treatment of psoriasis.
1991
1991
Effect of 1,25-dihydroxyvitamin D3 on adenylate cyclase and protein kinase C in pig epidermis.
1,25-dihydroxyvitamin D3 (1,25(OH)2D3) is suggested to be involved in the regulation of keratinocyte proliferation and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License